The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.
 
Kirsten Timms
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Inventor on numerous patents
Travel, Accommodations, Expenses - Myriad Genetics
 
Lauren Lenz
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Elizabeth S. Cogan
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
 
Erica L. Mayer
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis
Research Funding - Pfizer (Inst)
 
Virginia G. Kaklamani
Honoraria - AstraZeneca; daichi; Genentech; Genomic Health; Gilead Sciences; Novartis; Pfizer; Puma Biotechnology; Seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Athenex; bioTheranostics; Celldex; Eisai; Puma Biotechnology
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Genentech; Genomic Health; Novartis; Pfizer; Puma Biotechnology
Research Funding - Eisai
 
Vered Stearns
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Other Relationship - AstraZeneca
 
Vandana G Abramson
Employment - HCA Healthcare (I)
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Eisai
Research Funding - Genentech/Roche; Lilly
 
Carla Isadora Falkson
Honoraria - Curio Science; Exact Sciences
Consulting or Advisory Role - Agendia; bioTheranostics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Oncolytics (Inst); Pfizer/EMD Serono (Inst); QuantumLeap Health (Inst); Seagen (Inst)
 
Rachel Catherine Jankowitz
Honoraria - Eisai
Consulting or Advisory Role - Merck
Research Funding - Biotheranostics
 
P. Kelly Kelly Marcom
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Millennium (Inst); Novartis (Inst); Verily (Inst)
 
Nadine M. Tung
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)
 
William John Gradishar
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Genentech/Roche; merck; Pfizer; Puma Biotechnology; Seagen
 
James M. Ford
Research Funding - AstraZeneca (Inst); Bayer (Inst); Genentech (Inst); Incyte (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
 
Shaveta Vinayak
Consulting or Advisory Role - OncoSec
Research Funding - OncoSec (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
 
Judy Caroline Boughey
Honoraria - PeerView; PER; UpToDate
Consulting or Advisory Role - CairnSurgical
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Matthew P. Goetz
Consulting or Advisory Role - AstraZeneca (Inst); bioTheranostics; Biovica; Blueprint Medicines (Inst); Eagle Pharmaceuticals (Inst); Genzyme (Inst); Lilly; Novartis; Pfizer; Sermonix Pharmaceuticals
Research Funding - Lilly (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly
 
Anna Maria Storniolo
Employment - Q32 Bio (I)
Leadership - Q32 Bio (I)
Stock and Other Ownership Interests - Pfizer (I)
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Deerfield Management (I); Tri-Institutional Therapeutics Discovery Institute (I)
Research Funding - Pfizer (Inst)
 
Roisin M. Connolly
Other Relationship - Pfizer (Inst)
 
Andrea L. Richardson
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Inventor on HRD assay licensed to Myriad genetics. The IP is designated to Partners Healthcare. I am entitled to royalties and license fees.
 
Melinda L. Telli
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; G1 Therapeutics; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Merck; Natera; Novartis; OncoSec; Pfizer; Reflexion Medical; Sanofi
Research Funding - Abbvie (Inst); Bayer (Inst); Biothera (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics; Immunomedics